TUSCALOOSA, Ala. (WIAT) — Fibromyalgia affects as many as 5 million people over the age of 18. Approximately 80 to 90 percent of those are women.
The disorder causes aches and pain all over the body, with tender points along the neck, shoulders, hips and back.
People with fibromyalgia often experience numbness in the hands and feet, as well as sensitivity to light and extreme fatigue.
As such, treatment is often streamlined for each patient. Finding the right mix of medication and physical therapy can take time.
It can also be hard to diagnose, because the symptoms are often signs of so many other conditions.
Now, a Tuscaloosa-based biotech company is finished with phase two of testing for a drug that could help fibromyalgia patients.
It started 15 years ago in an effort to find ways to relieve the pain of people suffering from irritable bowl syndrome.
The research is on the right track towards finding a cure for fibromyalgia.
“There’s two medicines that hit the viruses in three different ways that actually will put the viruses to sleep, and then sort of miraculously, after a while, their body just sort of goes back to the way it was supposed to be,” said Dr. Skip Pridgen, the CEO of Innovative Med Concepts.
The research has already gotten attention from fibromyalgia sufferers worldwide.
The next step is winning over the medical community. Trials will enter Phase 2B in coming weeks, with a third and final phase to follow.
“There was a patient questionnaire that patients could fill out and seeing their comments,” said Rick Burch, the president of Innovative Med Concepts.
Learn more about Fibromyalgia here.
2014 WIAT-TV CBS42